Synthetic peptide vaccine development: designing dual epitopes into a single pilin peptide immunogen generates antibody cross-reactivity between two strains of Pseudomonas aeruginosa.
One of the main challenges of Pseudomonas aeruginosa vaccine development is the design of an antigen that elicits cross-reactive antibodies against multiple virulent strains. Using a rational design approach, we have developed a single 17-residue peptide immunogen that generates antibodies that target the receptor-binding domain of the type IV pilus of more than one strain of P. aeruginosa. Using the receptor-binding domain sequence, of native strain PAO as a template, we have systematically changed up to five residues in the PAO sequence of the peptide immunogen into that of the PAK sequence. We show by indirect and competitive ELISA that the mutant peptide immunogens elicit the development of polyclonal sera that is cross-reactive to both native strain PAO and PAK pilin. We further show that there are at least two separate antibody populations in the polyclonal sera that possess closely related epitopes but which are each strain specific. Moreover, part of the epitope for the PAO-specific antibodies consists of several residues outside the disulfide loop of the receptor-binding domain. This allows us to create two unique epitopes within the same receptor-binding domain sequence.
Hackbarth
Clifton
C
Department of Biochemistry and Molecular Genetics, University of Colorado Denver, School of Medicine, Program in Structural Biology and Biophysics, 12801 E. 17th Ave, MS 8101, Aurora, CO 80045, USA.
Hodges
Robert S
RS
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000907:Antibodies, Bacterial / Q000276:immunology* / Q000378:metabolism; D002352:Carrier Proteins / Q000737:chemistry / Q000276:immunology; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000737:chemistry / Q000276:immunology*; D036781:Fimbriae Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D008969:Molecular Sequence Data; D009154:Mutation; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry / Q000276:immunology; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D054406:Pseudomonas Vaccines / Q000737:chemistry / Q000276:immunology*; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000737:chemistry / Q000276:immunology
D000907:Antibodies, Bacterial; D002352:Carrier Proteins; D000939:Epitopes; D010455:Peptides; D054406:Pseudomonas Vaccines; D014614:Vaccines, Synthetic; D036781:Fimbriae Proteins
Mol Microbiol. 1994 Feb;11(4):705-13
7910938
Biochemistry. 2001 Apr 3;40(13):3985-95
11300779
Biochemistry. 2004 Sep 14;43(36):11427-35
15350129
Infect Immun. 1991 Mar;59(3):822-8
1671777
J Pept Res. 1998 Oct;52(4):289-99
9832307
Nat Rev Microbiol. 2004 May;2(5):363-78
15100690
J Mol Biol. 2000 Jun 16;299(4):1005-17
10843854
Bioconjug Chem. 1990 Mar-Apr;1(2):114-22
2095209
Nature. 2000 Aug 31;406(6799):959-64
10984043
Biochemistry. 1995 Dec 19;34(50):16255-68
8845350
Adv Microb Physiol. 1988;29:53-114
2898203
Biopolymers. 2003;71(2):141-68
12767116
Biochemistry. 1993 Dec 14;32(49):13432-40
8257679
Infect Immun. 1995 Apr;63(4):1278-85
7890385
Annu Rev Microbiol. 2002;56:289-314
12142488
J Biol Chem. 1988 Aug 25;263(24):11768-75
2457026
J Mol Biol. 2007 Nov 23;374(2):426-42
17936788
J Biomol NMR. 2001 Apr;19(4):385-6
11370789
Methods Enzymol. 1995;253:115-31
7476380
Infect Immun. 1994 Oct;62(10):4118-23
7927665
J Biol Chem. 2001 Jun 29;276(26):24186-93
11294863
Clin Infect Dis. 2005 Sep 15;41(6):848-54
16107985
Protein Sci. 1992 Oct;1(10):1308-18
1284654
Mol Cell. 2003 May;11(5):1139-50
12769840